Ensysce Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ensysce Biosciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 12% to $2,230,520. The net income raised on -$10,613,074 and profit margin reached -476%. Total operating expenses were $5,361,234.
Profit Margin
| 2017 | 0 | -31.19K | |
|---|---|---|---|
| 2018 | 0 | 2.12M | |
| 2019 | 1.76M | 1.47M | 83.7% |
| 2020 | 3.93M | -938.72K | -23.88% |
| 2021 | 3.53M | -29.14M | -825.38% |
| 2022 | 2.52M | -24.96M | -989.21% |
| 2023 | 2.23M | -10.61M | -475.81% |
ENSC Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 2.23M | 2.52M | 3.53M | 3.93M | 1.76M | 0 | 0 |
Cost of revenue | 7.58M | 19.83M | 151 | 1.36M | 3.32M | 1.55M | 0 |
Gross profit | -5.35M | -17.31M | 3.53M | 2.56M | -1.56M | -1.55M | 0 |
Operating exp. | |||||||
Research and development | 7.58M | 19.83M | 4.69M | 4.38M | 3.40M | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | -3.60M | 0 | 0 |
Total operating expenses | 5.36M | 24.22M | 19.87M | 1.61M | 3.32M | -600.00K | 146.69K |
Operating income | -10.71M | -24.22M | -19.87M | -1.61M | -3.32M | -959.24K | -146.7K |
Other income (expenses), net | 91.91K | 14.41K | -9.27M | 1.45M | 4.24M | 3.63M | 119.14K |
Income before tax | -10.62M | -24.20M | -29.14M | -160.87K | 921.15K | 2.67M | -27.55K |
Income tax expense | 0 | 753.87K | -151 | 777.85K | -555.2K | -553.91K | 3.63K |
Net income | -10.61M | -24.96M | -29.14M | -938.72K | 1.47M | 2.12M | -31.19K |
Earnings per share | |||||||
Basic EPS | -4.69 | -138.73 | -346.9 | -14.29 | 15.02 | 0.35 | -0.3 |
Diluted EPS | -4.69 | -138.73 | -346.9 | -13.65 | 15.02 | 0.35 | -0.3 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |